Trial | NCT04427930  Report issue

Title

Follow-up Study for Participants of Jointstem Phase 3 Clinical Trial
Long-Term Safety and Efficacy Extension Study Of Autologous Adipose-Derived Mesenchymal Stem Cells 『JOINTSTEM』 in Patients With Knee Osteoarthiritis: A Phase III Extension Study

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Active, not recruiting

  • Study Participants

    129
The purpose of this follow-up study is to investigate the efficacy and safety of autologous Adipose Tissue derived Mesenchymal stem cells (JOINTSTEM®) in patient with severe Knee Osteoarthritis.
Study Started
Apr 13
2020
Primary Completion
Dec 23
2026
Anticipated
Study Completion
Dec 30
2027
Anticipated
Last Update
Jul 10
2023

Biological JOINTSTEM

Autologous Adipose Tissue derived MSCs

JOINTSTEM Experimental

Long Term Follow-up after Jointstem Transplantation

Criteria 

Inclusion Criteria:

Participants of Jointstem Phase 3 Clinical Trial
Participates who signed informed consent document of this study

Exclusion Criteria:

No applicable
No Results Posted